As a biotech company, how do you determine when you are ready to go public? Our inaugural episode of BioDech, a global life sciences broadcast series, features guest speaker Philip Ross, global chairman of J.P. Morgan Investment Banking, and Dechert's Anna Tomczyk and Gregory Schernecke, partners in the firm's corporate and life sciences practices. 

Learn more.